Add BrightSurf on Google Email

Science News Archive January 2014 - Page 10


Page 10 of 28

Can personalized tumor vaccines improve interleukin-2 treated metastatic melanoma?

A new study found that combining high-dose interleukin-2 therapy with personalized tumor cell-based immunotherapy significantly improves patient survival rates. The treatment approach, which activates patients' immune systems using their own tumor cells, outperforms IL-2 alone in extending survival.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalCancer Biotherapy and Radiopharmaceuticals·DateJan 22, 2014

Texting changes the way we walk

A study published in PLOS ONE found that texting alters posture and balance while walking, causing individuals to swerve and slow down. This behavior may impact the safety of people who text and walk at the same time, highlighting the need for greater awareness about phone use while navigating.

SourcePLOS·JournalPublication Library and Information Science·DateJan 22, 2014

HRT cuts risk of repeat knee/hip replacement surgery by 40 percent

A large population-based study published in Annals of the Rheumatic Diseases found that hormone replacement therapy (HRT) taken regularly after knee or hip replacement reduces the risk of repeat surgery by around 40%. The research also showed that taking HRT for 12 months or more after surgery further decreases the risk, with those rec...

SourceBMJ Group·JournalAnnals of the Rheumatic Diseases·DateJan 22, 2014

A pill 'melts away' common form of leukemia

Scientists at Weill Cornell Medical College have found that a twice-daily pill, idelalisib, can turn deadly blood cancer into a highly treatable disease. The study suggests that patients with CLL may avoid debilitating chemotherapy, leading to significant side effects and death.

SourceWeill Cornell Medicine·JournalNew England Journal of Medicine·DateJan 22, 2014

Scripps Florida scientists offer new insight into neuron changes brought about by aging

Researchers at Scripps Florida Institute discovered significant changes in gene expression and neural circuitry as neurons age, shedding light on cognitive decline and potential therapeutic targets. The study, using the marine snail Aplysia californica, highlights the complex interplay between aging and neuron communication.

SourceScripps Research Institute·JournalJournal of Visualized Experiments·DateJan 22, 2014

Modest familial risks for multiple sclerosis

A new study from Karolinska Institutet found that the risk of relatives developing multiple sclerosis is lower than previously thought. The study analyzed data from over 28,000 individuals diagnosed with MS in Sweden, revealing a seven-fold increased risk for siblings and a five-fold increased risk for children of MS patients.

SourceKarolinska Institutet·JournalBrain·DateJan 22, 2014

Can fish oil help preserve brain cells?

A recent study published in Neurology suggests that fish oil consumption may help preserve brain cells by increasing total brain volume and hippocampus area size. The study found that higher levels of omega-3 fatty acids were associated with larger brain volumes, equivalent to a delay of one to two years of brain health.

SourceAmerican Academy of Neurology·JournalNeurology·DateJan 22, 2014

War on lionfish shows first promise of success

A new study confirms that reducing lionfish numbers by 75-95% can allow rapid recovery of native fish biomass and aid larger ecosystem recovery. Native species such as Nassau grouper and yellowtail snapper increased by 50-70% on reefs where lionfish were kept below threshold densities.

SourceOregon State University·JournalEcological Applications·DateJan 22, 2014

Malaria drug combo could help prevent pregnancy complications in lupus patients

Researchers at Yale University found that a combination of hydroxychloroquine may partially reverse the detrimental effects of antiphospholipid antibodies on human placental cell function, potentially benefiting pregnant women with lupus and/or antiphospholipid syndrome. This could lead to improved pregnancy outcomes for these patients.

SourceYale University·JournalAmerican Journal Of Reproductive Immunology·DateJan 22, 2014